APAC Pharmaceutical Gelatin Market

The size of the APAC Pharmaceutical Gelatin Market is estimated to hike at a prominent rate between 2022 to 2027.

The versatility and unique functional features of gelatin in pharmaceutical applications and the rising demand for gelatin capsules due to the rise in chronic illnesses and the aging population are driving the market growth. The gelatin coating on hard capsules, softgel capsules, and tablets hide the medicine's odor while also making swallowing easier. Furthermore, gelatin's qualities give protection against environmental changes such as oxygen or moisture, extending the shelf life of these products. Gelatin's functional solid properties drive the Asia Pacific pharmaceutical gelatin market. Increasing R&D spending to develop new forms and methods will also boost product demand. During the forecast period, rising demand in emerging economies, combined with decreased raw material and labor prices, would provide an opportunity for market expansion.

The increased demand for plant-based pharmaceutical products and consequential modifications in product portfolios by capsule makers are likely to constrain APAC pharmaceutical gelatin growth throughout the forecast period. Additionally, the handling of raw materials and production is governed by strict regulations to prevent the spread of animal-borne diseases. This can wreak havoc on supplies in the event of export or import bans and outbreaks of various diseases in specific places at any particular time. These factors will represent a substantial obstacle to the market's expansion during the forecast period. Furthermore, the high cost of gelatin, which is heavily used in the outer covering of capsules, and the availability of substitute components limit market expansion.

Transport and logistics challenges have arisen due to the quarantine and lockdown measures enforced in several regions, making it difficult to obtain raw material for pharmaceutical gelatin. This has caused a supply-demand gap in some areas, resulting in a shortage of medicinal gelatin. India and China, under lockdown for more extended periods, have been hit worse than others.

This market research report on the APAC Pharmaceutical Gelatin Market has been segmented and sub-segmented into the following categories:

By Function:

• Stabilizers
• Thickeners              
• Gelling Agents        

By Source:

• Pig Skin
• Bovine Hides
• Bones 
• Others

By Application:

• Hard Capsules        
• Soft Capsules          
• Micro Encapsulation           
• Coating     
• Absorbable Hemostats

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

During the forecast period, the pharmaceutical gelatin market in the Asia Pacific is expected to develop at the fastest rate. Major market participants are investing in this region because of the abundant availability of porcine and bovine sources of raw material and the low cost of labor and capital investment. These factors will drive the Asia Pacific region's growth in the predicted term. The Asia Pacific is the world's third-largest pharmaceutical market, with generics going the business in this region, aided by factors such as the aging population and the nearing expiration of patented pharmaceuticals. With a combined population of nearly four billion people, China, India, and other Asia Pacific countries are expected to become an increasingly primary driver of global consumption over the next two decades, owing to rapidly rising awareness about gelatin and a rapidly growing middle-class population. As a result, the pharmaceutical gelatin market in terms of value is expected to dominate the APAC.

KEY MARKET PLAYERS:

Rousselot, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Tessenderlo Group, Sterling Gelatin, Roxlor LLC, Weishardt, and Gelita AG are a few of the noteworthy companies operating in the APAC pharmaceutical gelatin market.